World News: 13:01 GMT Friday 9th November 2018. [Achaogen, Inc. via Globe Newswire via SPi World News]
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced that the Company will be presenting at the following investor conferences:
Live audio webcasts of the presentations will be available in the "Investors" section of Achaogen’s website, . Replays of each presentation will be archived for 30 days following the conference for those unable to listen live.
Source: Achaogen, Inc© 2018 Achaogen, Inc. All Rights Reserved.
Globe Newswire: 13:01 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.